{"id":2857,"date":"2023-03-14T18:18:27","date_gmt":"2023-03-14T23:18:27","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=2857"},"modified":"2023-03-14T18:35:24","modified_gmt":"2023-03-14T23:35:24","slug":"more-young-kids-can-get-bivalent-covid-booster","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/03\/14\/more-young-kids-can-get-bivalent-covid-booster\/","title":{"rendered":"More Young Kids Can Get Bivalent COVID Booster"},"content":{"rendered":"
\n

MedPageToday<\/a> Pfizer’s booster authorized in children under 5 who received three doses of monovalent vaccine<\/em> <\/p>\n\n\n\n

More children under age 5 are now eligible for a COVID-19 booster, the FDA announced<\/a> on Tuesday.<\/p>\n\n\n\n

Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster with the companies’ bivalent COVID vaccine — which targets the Omicron BA.4\/5 subvariants — as long as 2 months have passed, the agency said.<\/p>\n\n\n\n

“Today’s authorization provides parents and caregivers of children 6 months through 4 years of age who received the three-dose primary series with the monovalent [Pfizer shot] an opportunity to update their children’s protection by receiving a booster dose with the [bivalent vaccine],” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research (CDER), said in a statement.<\/p>\n\n\n\n

More children under age 5 are now eligible for a COVID-19 booster, the FDA announced <\/a>on Tuesday.<\/p>\n\n\n\n

Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster with the companies’ bivalent COVID vaccine — which targets the Omicron BA.4\/5 subvariants — as long as 2 months have passed, the agency said.<\/p>\n\n\n\n

“Today’s authorization provides parents and caregivers of children 6 months through 4 years of age who received the three-dose primary series with the monovalent [Pfizer shot] an opportunity to update their children’s protection by receiving a booster dose with the [bivalent vaccine],” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research (CDER), said in a statement.<\/p>\n\n\n\n

Since December 2022<\/a>, children in this age group who got their first two doses with the companies’ monovalent shot could complete their three-dose primary series with the bivalent vaccine. (At the time, Moderna’s bivalent vaccine was authorized as a booster dose as well, for kids ages 6 months to 5 years following a two-dose primary series.)<\/p>\n\n\n\n

Children who have received Pfizer’s bivalent vaccine as their third dose will not be eligible for a booster dose of a bivalent vaccine at this time “and are expected to have protection against the most serious COVID-19 outcomes,” according to an agency press release.<\/p>\n\n\n\n

The updated\u00a0emergency use authorization<\/a>\u00a0to allow for the fourth dose comes after reviewing immune response data from 60 children in this age group who had three doses of the monovalent vaccine and a bivalent booster, FDA said.<\/p>\n\n\n\n

One month after the bivalent booster, these kids “demonstrated an immune response to both the original SARS-CoV-2 virus strain and to Omicron BA.4\/BA.5,” the agency said in its release. <\/p>\n\n\n\n

Evidence of safety of a bivalent booster dose in this age group comes from previous data, FDA said, including studies evaluating the safety of an original strain\/BA.1 booster in adults age 55 and up; the monovalent primary series in kids 6 months and older; monovalent boosters in those age 5 and up; and postmarketing safety data with the monovalent and bivalent shots.<\/p>\n\n\n\n

Additional safety data come from two clinical studies involving pediatric patients that showed no new safety concerns and no previously unrecognized side effects with a bivalent booster, the FDA said.<\/p>\n<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"

MedPageToday Pfizer’s booster authorized in children under 5 who received three doses of monovalent vaccine More children under age 5 are now eligible for a COVID-19 booster, the FDA announced on Tuesday. Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster […]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"@Pfizer booster authorized in children under 5 who received three doses of monovalent #vaccine #covid","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[11,8],"tags":[],"class_list":["post-2857","post","type-post","status-publish","format-standard","hentry","category-covid","category-vaccine-headlines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/2857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=2857"}],"version-history":[{"count":3,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/2857\/revisions"}],"predecessor-version":[{"id":2862,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/2857\/revisions\/2862"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=2857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=2857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=2857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}